Squarepoint
KIN

Squarepoint’s Kindred Biosciences, Inc. KIN Stock Holding History

Squarepoint’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-126,905
Closed -$631K – 3979
2021
Q1 		$631K Buy
126,905
+111,172
+707% +$537K ﹤0.01% 1851
2020
Q4 		$68K Buy
+15,733
New +$64K ﹤0.01% 2771
2020
Q3 		– Sell
-72,941
Closed -$328K – 2989
2020
Q2 		$328K Buy
+72,941
New +$326K 0.01% 1545
2020
Q1 		– Sell
-41,086
Closed -$348K – 2781
2019
Q4 		$348K Buy
41,086
+26,863
+189% +$210K ﹤0.01% 1966
2019
Q3 		$97K Sell
14,223
-63,477
-82% -$466K ﹤0.01% 2197
2019
Q2 		$647K Buy
77,700
+28,682
+59% +$247K 0.01% 1518
2019
Q1 		$449K Buy
49,018
+23,894
+95% +$243K ﹤0.01% 1541
2018
Q4 		$275K Sell
25,124
-61,659
-71% -$777K ﹤0.01% 1542
2018
Q3 		$1.21M Buy
86,783
+47,445
+121% +$642K 0.01% 906
2018
Q2 		$419K Buy
39,338
+15,838
+67% +$154K 0.01% 1251
2018
Q1 		$203K Buy
23,500
+5,788
+33% +$50.8K ﹤0.01% 1488
2017
Q4 		$167K Buy
+17,712
New +$138K ﹤0.01% 1845

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Squarepoint's KIN Position: Q2 2021 in Review

Squarepoint sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 126,905 shares — an estimated $631K sold.

Squarepoint first reported a position in KIN in Q4 2017 and held it in 12 quarters. The position peaked at $1.21M in Q3 2018. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • Squarepoint reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 126,905 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $631K.
  • Squarepoint first reported a position in Kindred Biosciences, Inc. in Q4 2017 and held it in 12 quarters.
  • Squarepoint's Kindred Biosciences, Inc. position peaked at $1.21M in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.